Abstract
The aim of this study was to formulate and evaluate mucoadhesive sodium alginate microspheres for the nasal administration of Pentoxifylline to avoid first-pass metabolism. Microspheres were prepared using an ionic gelation process using a 23-factorial design. We investigated the effects of several factors on particle size and in–vitro mucoadhesion, including the drug-to-polymer weight ratio, calcium chloride (CaCl2) concentration, and cross-linking time. The particle size of the mucoadhesive microsphere was found in the 27.01 to 33.78 µm range, while the in vitro mucoadhesive result showed in the range 76.14 to 87.58%. The microspheres were characterized by SEM to study the shape and distribution of drugs within the microspheres. The surface morphology studied by SEM showed a spherical shape and the smooth surface of pentoxifylline-sodium alginate-loaded microspheres containing 2% w/v of Carbopol prepared by the ionotropic gelation method. The PM6 formulation shows highest percentage of in vitro diffusion (84.78%). In vitro dissolution tests were performed in a pH 6.2 phosphate buffer and indicated a non–Fickenian type of transport for the diffusion of drug from the Pentoxifylline mucoadhesive microsphere. It has been shown that the Hixson–Crowell model best describes the release of Pentoxifylline from Carbopol. The PM6 formulation utilized use of the Hixson–Crowell diffusion model of drug release, which was determined to be the model that best fit the data (r2 = 0.9697). The formulation showed that the Fickian mechanism of drug release was acting when the n value was less than 0.5.